Digoxin vs Ipilimumab

## Digoxin vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Digoxin** and **Ipilimumab**.

## Mechanism of Action

**Digoxin**: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Digoxin — 36-48 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Digoxin — C41H64O14; Ipilimumab — N/A.

**Molecular Weight**: Digoxin — 780.9430 g/mol; Ipilimumab — N/A.

**Type**: Digoxin — Small molecule; Ipilimumab — Antibody.